TherOx has started an investigational device exemption (IDE) pilot study of its new supersaturated oxygen (SSO2) therapy device, designed to salvage damaged cardiac muscle in patients with acute myocardial infarction (AMI). The TherOx ...
Tags: TherOx, therapy device, Medical
There is a shortage of big data modellers as well as data scientists, according to the senior vice president of IT research firm Infosys Labs, Subu Goparaju. Infosys Labs is the research arm of IT business consulting firm Infosys, ...
Tags: data modellers, IT research, Infosys Labs
The Principal Financial Group has introduced a voluntary critical illness insurance to help employees fill the gap in financial protection, due to added expenses that are not covered by medical insurance. Covering five most common ...
Tags: Principal Financial Group, critical illness insurance, medical insurance
It seems to be generally accepted by the medical profession that in the event of a heart attack, stroke or brain trauma it significantly improves the prognosis for the patient if the brain can be cooled at the earliest possible opportunity. ...
If you think leaving the hospital means you're home for good, think again. About twenty percent of heart attack and pneumonia patients, and a quarter of heart failure patients, find themselves back in the hospital within 30 days, according ...
Tags: hospital, Medicare, Medicaid Services, hospital safety
For almost two decades research has suggested that people with diabetes and multiple clogged arteries live longer and have fewer heart attacks if they undergo bypass surgery instead of angioplasty. Yet many of those people continue to be ...
Tags: diabetes, multiple clogged arteries, healthcare, heart attacks
Abbott has obtained CE mark approval for its Architect Stat high sensitive Troponin-I assay, designed for evaluating potential heart attacks sooner. The chemiluminescent microparticle immunoassay (CMIA), which is designed for use on ...
Tags: Abbott, CE mark, Architect Stat, potential heart attacks
Accumetrics' VerifyNow II System has received CE marking for point-of-care measurement of platelet reactivity to antiplatelet agents. The receival of Ce mark is expected to expand the market opportunities for the VerifyNow System in both ...
Tags: Accumetrics, VerifyNow II System, CE marking, platelet reactivity
Fugitive antivirus pioneer John McAfee could soon be released from detention in Guatemala where he is being held on charges that he entered the country illegally in an attempt to escape authorities in Belize where he is wanted for ...
Tags: McAfee, Antivirus software, software, McAfee software
Pacemakers from several manufacturers can be commanded to deliver a deadly, 830-volt shock from someone on a laptop up to 50 feet away, the result of poor software programming by medical device companies. The new research comes from ...
Tags: Pacemakers, shock, laptop, software programming, medical device companies
Angel Medical Systems, a developer of continuous intracardiac ischemia monitoring technologies, has raised $27.5m in the financing round. In the round, Angel's existing venture capital, strategic partner and investors, as well as a ...
Tags: clinical trial, financing round, clinical technology, investment
Atherotech Diagnostics Lab, a CLIA-certified clinical reference laboratory, has entered into an agreement to offer BG Medicine's galectin-3 testing services to laboratory customers and physicians. To offer the services, Atherotech is ...
CardioKinetix has reported positive three-year clinical data of its minimally invasive Parachute ventricular partitioning device, following Percutaneous Ventricular Restoration therapy in heart failure patients. The Parachute device, ...
Tags: CardioKinetix, clinical data, Parachute, ventricular partitioning device
Miracor Medical Systems has treated first three ST segment elevation myocardial infarction (STEMI) patients, enrolled in the Prepare Ramses study, using its pressure-controlled intermittent coronary sinus occlusion (PICSO) impulse system ...
Ventus Medical has launched a non-invasive therapy, designed to treat mild, moderate, and severe obstructive sleep apnea (OSA), in the province of Ontario, Canada. Featuring MicroValve design, the Provent sleep apnea therapy uses ...
Tags: Non-Invasive Therapy, obstructive sleep apnea, clinical product